MX2007016373A - Compuestos de piridil y piridonil estereoisomericos y metodos para el tratamiento de trastornos gastrointestinales y del sistema nervioso central. - Google Patents
Compuestos de piridil y piridonil estereoisomericos y metodos para el tratamiento de trastornos gastrointestinales y del sistema nervioso central.Info
- Publication number
- MX2007016373A MX2007016373A MX2007016373A MX2007016373A MX2007016373A MX 2007016373 A MX2007016373 A MX 2007016373A MX 2007016373 A MX2007016373 A MX 2007016373A MX 2007016373 A MX2007016373 A MX 2007016373A MX 2007016373 A MX2007016373 A MX 2007016373A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- nervous system
- central nervous
- stereoisomeric
- pyridonyl
- Prior art date
Links
- 208000015114 central nervous system disease Diseases 0.000 title 1
- 208000010643 digestive system disease Diseases 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
- 125000005494 pyridonyl group Chemical group 0.000 title 1
- 125000004076 pyridyl group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 206010021518 Impaired gastric emptying Diseases 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 1
- 208000001288 gastroparesis Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69666205P | 2005-07-05 | 2005-07-05 | |
| PCT/US2006/026166 WO2007005951A2 (fr) | 2005-07-05 | 2006-07-05 | Composes de pyridyle et de pyridonyle stereoisomeriques et methodes de traitement des troubles gastro-intestinaux et des troubles du systeme nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007016373A true MX2007016373A (es) | 2008-04-29 |
Family
ID=37463520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007016373A MX2007016373A (es) | 2005-07-05 | 2006-07-05 | Compuestos de piridil y piridonil estereoisomericos y metodos para el tratamiento de trastornos gastrointestinales y del sistema nervioso central. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1907376A2 (fr) |
| JP (1) | JP2009500419A (fr) |
| CN (1) | CN101258145A (fr) |
| CA (1) | CA2612893A1 (fr) |
| MX (1) | MX2007016373A (fr) |
| WO (1) | WO2007005951A2 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8138204B2 (en) | 2004-01-07 | 2012-03-20 | Aryx Therapeutics, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| US8524736B2 (en) | 2004-01-07 | 2013-09-03 | Armetheon, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| BRPI0820171B8 (pt) | 2007-11-16 | 2021-05-25 | Rigel Pharmaceuticals Inc | compostos de carboxamida, sulfonamida e amina para distúrbios metabólicos, composição farmacêutica, e, uso dos mesmos |
| CA2707047C (fr) | 2007-12-12 | 2017-11-28 | Rigel Pharmaceuticals, Inc. | Composes de carboxamide, de sulfonamide et d'amine servant a traiter les troubles metaboliques |
| MX2010011288A (es) | 2008-04-23 | 2010-11-09 | Rigel Pharmaceuticals Inc | Compuestos de carboxamida para el tratamiento de trastornos metabolicos. |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| WO2011092290A1 (fr) | 2010-02-01 | 2011-08-04 | Novartis Ag | Dérivés de pyrazolo[5,1-b] utilisés en tant qu'antagonistes du récepteur de crf-1 |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| EP2531490B1 (fr) | 2010-02-02 | 2014-10-15 | Novartis AG | Dérivés de cyclohexylamide à titre d'antagonistes du récepteur crf |
| EP3978487A1 (fr) * | 2020-09-30 | 2022-04-06 | Origo Biopharma, S.L. | Dérivés de 2-(3-pyridine-2-yl-4-quinoline-4-yl-pyrazol-1-yl)-acétamide comme inhibiteurs du récepteur du facteur de croissance transformant bêta i/alk5 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03000145A (es) * | 2002-01-07 | 2003-07-15 | Pfizer | Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4. |
| JP2005082508A (ja) * | 2003-09-05 | 2005-03-31 | Dainippon Pharmaceut Co Ltd | ２−アルコキシ−６−アミノ−５−ハロゲノ−ｎ−（１−置換−４−ピペリジニル）ピリジン−３−カルボキサミド誘導体およびそれを含有する医薬組成物 |
| JP2005104896A (ja) * | 2003-09-30 | 2005-04-21 | Dainippon Pharmaceut Co Ltd | ２−アルコキシ−６−アミノ−５−ハロゲノピリジン−３−カルボキサミド誘導体およびそれを含有する医薬組成物 |
-
2006
- 2006-07-05 WO PCT/US2006/026166 patent/WO2007005951A2/fr not_active Ceased
- 2006-07-05 CA CA002612893A patent/CA2612893A1/fr not_active Abandoned
- 2006-07-05 JP JP2008520356A patent/JP2009500419A/ja active Pending
- 2006-07-05 MX MX2007016373A patent/MX2007016373A/es not_active Application Discontinuation
- 2006-07-05 CN CNA2006800322117A patent/CN101258145A/zh active Pending
- 2006-07-05 EP EP06774511A patent/EP1907376A2/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009500419A (ja) | 2009-01-08 |
| WO2007005951A3 (fr) | 2007-03-29 |
| CN101258145A (zh) | 2008-09-03 |
| WO2007005951A2 (fr) | 2007-01-11 |
| CA2612893A1 (fr) | 2007-01-11 |
| EP1907376A2 (fr) | 2008-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL176569A0 (en) | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders | |
| CY1117045T1 (el) | Ενωσεις κινουκλιδινης ως προσδετες του νικοτινικου υποδοχεα ακετυλχολινης αλφα-7 | |
| GEP20084420B (en) | Use of imidazole compounds for the treatment of neurodegenerative disorders | |
| MY148985A (en) | 2-aminopyridine analogs as glucokinase activators | |
| TW200639166A (en) | Amino-pyridines as inhibitors of β-secretase | |
| TW200716558A (en) | Heteroaroyl-substituted serineamides | |
| GB2442915B (en) | Perylenequinone derivatives and uses thereof | |
| TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
| MX2009007231A (es) | Compuestos quimicos 637:piridopirimidindionas como inhibidores de la fosfodiesterasa 4. | |
| ATE521608T1 (de) | Glucokinaseaktivatoren | |
| UA92503C2 (ru) | Соединения 5-(фенилизоксазолилэтокси)-триазол-3-ил-замещенного пиридина для лечения неврологических, психиатрических или болевых расстройств | |
| TNSN07165A1 (en) | Organic compounds | |
| MX2007016373A (es) | Compuestos de piridil y piridonil estereoisomericos y metodos para el tratamiento de trastornos gastrointestinales y del sistema nervioso central. | |
| WO2007028073A3 (fr) | Methodes synthetiques et intermediaires de composes stereoisomeres utiles dans le traitement des troubles gastro-intestinaux et du systeme nerveux central | |
| TW200700064A (en) | Novel compounds | |
| MX2008001428A (es) | Compuestos de imidazolil-pirimidina para uso en el tratamiento de trastornos proliferativos. | |
| NO20064974L (no) | terapeutiske midler | |
| ATE526025T1 (de) | Behandlung metastasierter tumore | |
| TW200738143A (en) | Use of arylanilides for seed treatment | |
| TW200728300A (en) | Therapeutic agents | |
| TNSN08268A1 (en) | Crystalline form of vinflunine ditartrate | |
| WO2010107791A3 (fr) | Composés de pyrazinoisoquinoline | |
| NO20076063L (no) | Prodroger av N-tiazol-2-yl-benzamidderivater | |
| BG110157A (en) | INDONAL COMPOUNDS USE FOR TREATMENT OF DISABILITY OF KNOWLEDGE COMPETENCE | |
| WO2004022041A3 (fr) | Traitement de la rhinite non allergique au moyen d'inhibiteurs selectifs de phosphodiesterase-4 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |